Sensitivity Analyses of the Change in FVC in a Phase 3 Trial of Pirfenidone for Idiopathic Pulmonary Fibrosis

BACKGROUND: FVC outcomes in clinical trials on idiopathic pulmonary fibrosis (IPF) can be substantially influenced by the analytic methodology and the handling of missing data. We conducted a series of sensitivity analyses to assess the robustness of the statistical finding and the stability of the...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Chest
Main Authors: Lederer, David J., Bradford, Williamson Z., Fagan, Elizabeth A., Glaspole, Ian, Glassberg, Marilyn K., Glasscock, Kenneth F., Kardatzke, David, King, Talmadge E., Lancaster, Lisa H., Nathan, Steven D., Pereira, Carlos A., Sahn, Steven A., Swigris, Jeffrey J., Noble, Paul W.
Format: Artigo
Jezik:Inglês
Izdano: American College of Chest Physicians 2015
Teme:
Original Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4493875/
https://ncbi.nlm.nih.gov/pubmed/25856121
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1378/chest.14-2817
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki